DrugPatentWatch Database Preview
Details for Biologics License Application: 103234
» See Plans and Pricing
Summary for BLA: 103234
| Tradename: | EPOGEN/PROCRIT |
| Applicant: | Amgen |
| Ingredient: | epoetin alfa |
| Patents: | 99 |
| Approval Date: | Jun 01, 1989 |
| Suppliers: see list | 2 |
Pharmacology for BLA: 103234
| Ingredient-type | Erythropoietin |
| Drug Class | Erythropoiesis-stimulating Agent |
| Physiological Effect | Increased Erythroid Cell Production |
US Patents for BLA: 103234
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | AMGEN INC. (Thousand Oaks, CA) | 2039-02-26 | RX | search | |
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | 2036-04-01 | RX | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
